Prosecution Insights
Last updated: August 17, 2026
Application No. 18/912,023

AUTOMATING DATA DOWNLOAD IN A SYSTEM REQUIRING RESPONSIVENESS TO A SECONDARY CONTROL UNIT

Non-Final OA §102§103
Filed
Oct 10, 2024
Priority
Oct 12, 2023 — provisional 63/543,826
Examiner
TURCHEN, ROCHELLE DEANNA
Art Unit
Tech Center
Assignee
Boston Scientific Corporation
OA Round
1 (Non-Final)
57%
Grant Probability
Moderate
1-2
OA Rounds
2y 3m
Est. Remaining
87%
With Interview

Examiner Intelligence

Grants 57% of resolved cases
57%
Career Allowance Rate
377 granted / 662 resolved
-3.1% vs TC avg
Strong +30% interview lift
Without
With
+29.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
23 currently pending
Career history
690
Total Applications
across all art units

Statute-Specific Performance

§101
6.4%
-33.6% vs TC avg
§103
50.2%
+10.2% vs TC avg
§102
15.1%
-24.9% vs TC avg
§112
23.3%
-16.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 662 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 12-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 30 June 2026. Applicant’s election without traverse of Inventions I and II in the reply filed on 30 June 2026 is acknowledged. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-9 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Young et al (9,463,325). Regarding claim 1, Young et al disclose a system for regulating data downloads from an implantable pulse generator (IPG) (the IMD 101 may be…an implantable pulse generator (IPG) – col.4, ll.35-46), comprising: an IPG configured to download data, receive operation signals and provide electrical stimulation to a patient (the IMD 700 may include an implantable pulse generator (IPG) 750…the IPG 750 may be an external neuro pulse generator – col.19, l.37 and col.19, l.64-col.20, l.1); and at least a first external device configured to initiate a first data download from the IPG to the first external device, the first external device configured to direct the IPG to download the data for a first time period, wherein the first time period is preset (fig. 5 illustrates a timing diagram 500 of transmissions between the external device 201 and the IMD 101 – col.11, ll.29-30; the external device 201 and the IMD 101 exchange data packets 530a and 540a within the communication interval 502a over the select data channel during the connection interval 502a – col.13, ll.39-42); wherein the IPG and/or the first external device is configured to stop the data download after the first time period has expired (the CPU 302 of the external device 201 – col.11, ll.54-55; the RF subsystem 330 may continually repeat the scanning interval 503 until the CPU 302 acknowledges receipt of the advertisement notice 505 – col.11, l.67-col.12, l.1); wherein the IPG and/or the first external device is configured to wait a first time interval during which no data is downloaded and the IPG is available to receive signals from any external control devices (the RF subsystem may repeat the scanning interval 503 every scan period – col.11, ll.57-58); wherein the IPG and/or the first external device is configured to initiate an additional download from the IPG to the first external device for a second time period after the first time interval has expired (when the data packet 540a is received by the external device 201 indicating the end of the communication interval 502a, the RF circuit 354 of the external device 201 may shift to the second data channel for the communication interval 502b – col.13, ll.46-50); wherein the IPG and/or the first external device is configured to repeat the initiating, stopping, waiting and initiating additional data download steps until all data has been downloaded from the IPG to the first external device (a termination request may be included in the data packet 530e from the external device 201 – col.18, ll.10-15; 540E – fig.5). Regarding claim 2, Young et al disclose wherein the first external device is a remote control, bedside monitor, or other device with a monitoring application (the external device 201 may be a portable computer, tablet computer, an IMD programmer, a PDA, a cell phone and/or the like located within a home of the patient 106, a hospital or clinic, an automobile, at an office of the patient, or the like – col.9, ll.54-58). Regarding claim 3, Young et al disclose wherein the first external device is configured to communicate with the IPG via a Bluetooth connection (the bi-directional communication link 104 may use any standard wireless protocol such as…Bluetooth – col.4, ll.28-30). Regarding claim 4, Young et al disclose wherein the IPG and/or the first external device is configured to measure activity level of the patient (“rate-responsive” sensor, to record the activity level of the patient – col.9, ll.2-3). Regarding claim 5, Young et al disclose wherein the IPG and/or the first external device includes an accelerometer (IMD 101 may also include a physiologic sensor 112, such as an accelerometer – col.9, ll.1-2). Regarding claim 6, Young et al disclose a method for regulating data downloads from an implantable pulse generator (IPG) (the IMD 101 may be…an implantable pulse generator (IPG) – col.4, ll.35-46), comprising: initiating a first data download from the IPG to the first external device, the first external device configured to direct the IPG to download the data for a first time period, wherein the first time period is preset (fig. 5 illustrates a timing diagram 500 of transmissions between the external device 201 and the IMD 101 – col.11, ll.29-30; the external device 201 and the IMD 101 exchange data packets 530a and 540a within the communication interval 502a over the select data channel during the connection interval 502a – col.13, ll.39-42); stopping the data download after the first time period has expired (the CPU 302 of the external device 201 – col.11, ll.54-55; the RF subsystem 330 may continually repeat the scanning interval 503 until the CPU 302 acknowledges receipt of the advertisement notice 505 – col.11, l.67-col.12, l.1); waiting a first time interval during which no data is downloaded and the IPG is available to receive signals from any external control devices (the RF subsystem may repeat the scanning interval 503 every scan period – col.11, ll.57-58); after the first time interval has expired, then initiating an additional download from the IPG to the first external device for a second time period after the first time interval has expired (when the data packet 540a is received by the external device 201 indicating the end of the communication interval 502a, the RF circuit 354 of the external device 201 may shift to the second data channel for the communication interval 502b – col.13, ll.46-50); repeating the initiating, stopping, waiting and initiating additional data download steps until all data has been downloaded from the IPG to the first external device (a termination request may be included in the data packet 530e from the external device 201 – col.18, ll.10-15; 540E – fig.5). Regarding claim 7, Young et al disclose wherein the first external device is a remote control for the IPG, bedside monitor, or other device with a monitoring application (the external device 201 may be a portable computer, tablet computer, an IMD programmer, a PDA, a cell phone and/or the like located within a home of the patient 106, a hospital or clinic, an automobile, at an office of the patient, or the like – col.9, ll.54-58). Regarding claim 8, Young et al disclose wherein the first external device is a cell phone (the external device may be…a cell phone – col.9, ll.54-58). Regarding claim 9, Young et al disclose wherein initiating the first and additional data downloads from the IPG to the first external device occurs over a Bluetooth connection (the bi-directional communication link 104 may use any standard wireless protocol such as…Bluetooth – col.4, ll.28-30). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 10 and 11 is/are rejected under 35 U.S.C. 103 as being unpatentable over Young et al (9,463,325) in view of Doudian et al (2022/0104293). Regarding claims 10 and 11, Young et al disclose the data stored in memory 194 may be selectively stored at certain time intervals (col.7, ll.60-32), but fail to explicitly disclose wherein the first and second time periods are each between 30 seconds and two minutes and wherein in the first time interval is between 30 seconds and two minutes. However, Doudian et al teach in the same medical field of endeavor, wherein a first and second time periods are each between 30 seconds and two minutes (fast advertising mode duration may be on the order of a few minutes – [0038]) and wherein in the first time interval is between 30 seconds and two minutes (inactivity duration may be one the order of one minute or so – [0038]). It would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to modify the certain time intervals as well as the first and second time periods and the first time interval of Young et al with a time period of 30 second to two minutes as it would provide the user with the ability to set a desired download period and inactivity period. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROCHELLE DEANNA TURCHEN whose telephone number is (571)270-7104. The examiner can normally be reached Mon - Fri 6:30-2:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christopher Koharski can be reached at (571)272-7230. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ROCHELLE D TURCHEN/Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Oct 10, 2024
Application Filed
Jul 27, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702562
SYSTEMS AND METHODS FOR KNEE ARTHROPLASTY
2y 11m to grant Granted Aug 11, 2026
Patent 12697059
APPARATUS, METHODS AND COMPUTER-ACCESSIBLE MEDIA FOR IN SITU THREE-DIMENSIONAL RECONSTRUCTION OF LUMINAL STRUCTURES
1y 8m to grant Granted Aug 04, 2026
Patent 12690759
TUBING FLOW CONTROL FOR ENDOSCOPIC SYSTEM
3y 1m to grant Granted Jul 28, 2026
Patent 12690846
MEDICAL IMAGE PROCESSING APPARATUS, X-RAY DIAGNOSTIC SYSTEM, AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM STORING MEDICAL IMAGE PROCESSING PROGRAM
2y 11m to grant Granted Jul 28, 2026
Patent 12691291
IMPLANTABLE MEDICAL DEVICE AND METHODS FOR MANUFACTURING AN IMPLANTABLE HOUSING
1y 11m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
57%
Grant Probability
87%
With Interview (+29.7%)
4y 1m (~2y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 662 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month